共 16 条
[1]
Lai CL,Leung N,Teo EK,et al.A1-year trial of telbivudine,lamive-dine,and the combination in patients with hepatitis B e antigen-positive chronic hepatitis B. Gastroenterology . 2005
[2]
Keeffe EB,Oieterich DT,Han S HB,et al.Atreatment alogorithmfor the management of chronic hepatitis B virus infection n the United States:an update. Clinic Gastroenterol Hepatology . 2006
[3]
Chang TT,Lai CL,Chien RN,et al.Four years of lamivudine treatment in Chinese patients with chronic hepatitis B. Journal of Gastroenterology . 2004
[4]
Dore GJ,Guan R,WasimJafri SM,Sarin SV,Keeffe EB.Management of chronic hepatitis B in challenging patient populations. Liver International . 2006
[5]
Chang TT,Jia JD,Omata M.Newtherapies for chronic hepatitis Binfec-tion. Liver International . 2006
[6]
Fung SK,Wong F,Hussain M,et al.Sustained response after a2-year course of lamivudinetreatment of hepatitis Be antigen-negative chronic hep-atitis B. Journal of Viral Hepatitis . 2004
[7]
Tenney DJ,Levine SM,Rose RE,et al.Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant tolamivedine. Antimicrobial Agents and Chemotherapy . 2004
[8]
van Bommel F,Wunsche T,Mauss S,et al.Comparison of adefovir and tenofovir inthe treatment of lamivedine-resistant hepatitis Bvirusinfection. Hepatology . 2004
[9]
Hadziyannis S,Tassopoulos N,Chang TT,et al.Long-termadefovir dipiv-oxil treatment induces regression of liver fibrosis in patients with HBeAg-negative chronic hepatitis B:results after5years of therapy. Hepatology . 2005
[10]
Papatheodoridis GV,Manesis E,Hadziyannis SJ.Thelong-termoutcome of interferon-alpha treated and untreated patients with HBeAg-negative chronic hepatitis B. Journal of Hepatology . 2001